Neogen Chemicals Q4 FY26: Revenue Up 22% to ₹246.6 Cr, PAT Jumps 373% to ₹11.4 Cr
Neogen Chemicals reported Q4 FY26 consolidated revenue up 22% to ₹246.6 crore and PAT up 373% to ₹11.4 crore. Full year FY26 consolidated revenue rose 11% to ₹862 crore. Promoters infused ₹161 crore via preferential allotment. Dahej reconstruction to complete by June 2026. FY27 revenue guidance is ₹875-950 crore.
The strong quarterly results, significant promoter investment, and positive future outlook are material events that are likely to have a considerable impact on the company's stock performance and investor sentiment.
The company reported significant year-on-year growth in revenue and PAT for the fourth quarter of FY26, along with a substantial capital infusion from promoters and positive future revenue guidance.
Neogen Chemicals Limited announced its audited financial results for the quarter and financial year ended March 31, 2026. For the fourth quarter of FY26, the company reported a consolidated revenue of ₹246.6 crore, a 22% increase compared to ₹202.8 crore in Q4 FY25. Consolidated Profit After Tax (PAT) surged by 373% to ₹11.4 crore from ₹2.4 crore in the same period last year.
On a standalone basis, revenue for Q4 FY26 grew by 22% to ₹248.6 crore from ₹203.8 crore in Q4 FY25. Standalone PAT saw a significant jump of 182% to ₹14.7 crore from ₹5.2 crore year-on-year.
For the full financial year FY26, consolidated revenue increased by 11% to ₹862 crore from ₹777.6 crore in FY25. Consolidated PAT for FY26 stood at ₹28.8 crore, a decrease of 17% compared to ₹34.8 crore in FY25. Standalone revenue for FY26 was ₹855.5 crore, an 11% rise from ₹773.7 crore in FY25, while standalone PAT decreased by 3% to ₹47.0 crore from ₹48.4 crore in FY25.
The company also highlighted progress on its expansion initiatives, including the Dahej fire incident reconstruction, which is on track for commissioning by June 2026. Neogen Ionics' battery chemicals business saw Q4 FY26 revenue of ₹13 crore and FY26 revenue of ₹36 crore. The company's board recommended a final dividend of ₹1 per equity share for FY26, subject to shareholder approval. Furthermore, the promoters infused ₹161 crore through a preferential allotment at ₹1,610 per share to support Neogen Ionics' expansion, working capital, and general corporate purposes. The company has revised the project timelines and aggregate cost for its Dahej Phase 1 and Pakhajan Phase 2 Battery Materials projects to INR 1,795 crore, with expected completion by February 2027 and March 2027, respectively.
Management commentary indicated confidence in achieving standalone revenues in the range of ₹875–950 crore in FY27, driven by the commissioning of the Pakhajan greenfield facility and the Dahej plant's ramp-up.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.